Jefferson M. Jones
- Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
2023/08/24 by Jefferson M. Jones, Katherine E. Fleming-Dutra, Mila M. Prill +9 · 5 citations
Medicine · #Neonatal Respiratory Health Research #Pneumonia and Respiratory Infections #Respiratory viral infections research
- Public Health Responses to COVID-19 Outbreaks on Cruise Ships — Worldwide, February–March 2020
2020/03/23 by Leah F. Moriarty, Mateusz M. Plucinski, Mateusz M. Pluciński +142 · 3 citations
Environmental Science · Mathematics · Medicine · #COVID-19 epidemiological studies #COVID-19 impact on air quality #Travel-related health issues
- Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months — United States, April 2024
2024/09/26 by Hilda Razzaghi, Emma Garacci, Katherine E. Kahn +5 · 4 citations
Medicine · #Respiratory viral infections research #Viral gastroenteritis research and epidemiology #Viral Infections and Vectors
- Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States—October 25, 2020–February 26, 2022
2022/12/02 by Ryan E. Wiegand, Yangyang Deng, Xiaoyi Deng +11 · 1 voice · 1 citation
Medicine · #COVID-19 Clinical Research Studies #SARS-CoV-2 and COVID-19 Research #SARS-CoV-2 detection and testing
- Telling the right patient.
1981/07/25 by Jefferson M. Jones · 1 citation
Business, Management and Accounting · Medicine · Health Professions · #Healthcare Systems and Technology #Clinical Laboratory Practices and Quality Control #Health Sciences Research and Education